Hempstract, Inc.
OTC: HPST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ronald M. Herzfeld
- Employees
- 2
- Headquarters
- Warden, United States
- IPO year
- 2021
- Market cap
- $25.5M
- Website
- https://www.hempstractlabs.com
Loading HPST…
Loading profile data…Frequently asked questions about HPST
What does Hempstract, Inc. (HPST) do?
Operating across the United States, Hempstract, Inc. develops and supplies products centered around cannabidiol (CBD) and cannabigerol (CBG). Its catalog features CBD in isolate powder form, alongside various distillate oils. The enterprise adopted the Hempstract, Inc. moniker in November 2020, having previously been known as Riverdale Oil and G...
Where does HPST trade?
Hempstract, Inc. (HPST) trades on the Other OTC.
What sector is HPST in?
Hempstract, Inc. (HPST) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hempstract, Inc.?
Ronald M. Herzfeld is the chief executive officer of Hempstract, Inc. (HPST).
Where is Hempstract, Inc. headquartered?
Hempstract, Inc. is headquartered in United States.
Does HPST pay a dividend?
Hempstract, Inc. (HPST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HPST go public?
Hempstract, Inc. (HPST) completed its initial public offering in 2021.